- Born:
- December 16, 1928, New York City, New York, U.S.
- Died:
- October 5, 2024, Berkeley, California (aged 95)
- Subjects Of Study:
- aging
- cancer
- carcinogen
- human exposure/rodent potency index
- mitochondrion
- mutagen
Bruce Ames
-
Who is Bruce Ames?
Bruce Ames (1928ā2024) was a distinguished American biochemist and geneticist renowned for developing the Ames test, a rapid and inexpensive method for identifying chemical mutagens by assessing their ability to induce mutations in Salmonella typhimurium.
Initially hailed as an environmental hero for his test's role in banning carcinogenic synthetic chemicals, Ames later stirred controversy by highlighting the carcinogenic potential of naturally occurring substances. This led him to challenge what he viewed as an idyllic, antitechnology perspective of environmentalists. Ames also argued that rising cancer rates were primarily due to increased longevity rather than pollution. He advocated for a diet rich in fruits and vegetables to prevent cancer and introduced the HERP index to rate chemical carcinogenesis based on animal studies.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What kind of science did Bruce Ames study?
Bruce Ames, an American biochemist and geneticist, significantly contributed to the fields of biochemistry and genetics.
Ames graduated from Cornell University with a B.A. in chemistry and a minor in biology. He obtained a Ph.D. in biochemistry from the California Institute of Technology in 1953. His research focused on isolating enzymes and genes involved in histidine biosynthesis, utilizing Salmonella as his model organism. Later, he developed the Ames test, a rapid and inexpensive method for assessing the mutagenic and carcinogenic risks of chemicals.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is Bruce Ames best known for inventing?
Bruce Ames is best known for inventing the Ames test, which identifies potential carcinogens by studying their mutagenic effect on bacteria. Introduced in the 1970s, the Ames test assesses the ability of chemicals to induce mutations in the bacterium Salmonella typhimurium.
The rapid and inexpensive nature of the test made it more effective for initial mutagenicity screens than existing epidemiological surveys and animal tests. It has been widely used to assess the mutagenic and carcinogenic risks of a large number of chemicals, allowing scientists to determine whether various chemicals pose health risks to humans. Thanks to the test, certain synthetic chemicals that were once commonly used have been banned.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How does the Ames test help scientists?
The Ames test, developed by Bruce Ames, helps scientists identify potential carcinogens by examining the mutagenic effects of chemicals on bacteria. This rapid and inexpensive test assesses whether chemicals can induce mutations in Salmonella typhimurium, allowing scientists to determine if substances pose health risks to humans.
Due to Ames's analysis, several synthetic chemicals once in common use have been banned. The assessments stemming from the Ames test have been widely used to determine the mutagenic and carcinogenic risks of numerous chemicals, helping to ban certain synthetic chemicals.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
Why is testing chemicals for mutagenicity important?
Testing chemicals for mutagenicity is important because mutagens can alter a cell's genetic structure by changing its DNA. Many natural and human-made agents can cause genetic damage, and many industrial chemicals are mutagens, some of which are carcinogenic.
The Ames test, developed by Bruce Ames, is a rapid and inexpensive test for mutagenicity using Salmonella typhimurium. It helps determine if chemicals pose health risks to humans by assessing their ability to induce mutations. This test has led to bans on certain synthetic chemicals.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How did Bruce Amesās work impact the study of genetics and public health?
Bruce Ames's work significantly impacted genetics and public health through the Ames test, introduced in the 1970s. This rapid, inexpensive test assessed a chemical's ability to cause mutations in Salmonella typhimurium, effectively screening for potential carcinogens.
Ames's work led to the banning of certain synthetic chemicals, such as Tris, a flame retardant used in childrenās sleepwear, and allowed scientists to determine whether various chemicals pose health risks to humans. His research later revealed that natural chemicals could be as carcinogenic as synthetic ones, challenging the view that human-made chemicals are inherently more dangerous. This led him to advocate for a balanced perspective on chemical risks and to promote the consumption of fruits and vegetables for cancer prevention.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
Bruce Ames (born December 16, 1928, New York City, New York, U.S.ādied October 5, 2024, Berkeley, California) was an American biochemist and geneticist who developed the Ames test for chemical mutagens. The test, introduced in the 1970s, assessed the ability of chemicals to induce mutations in the bacterium Salmonella typhimurium. Because of its sensitivity to carcinogenic (cancer-causing) human-made substances, which led to bans on the commercial use of several synthetic chemicals, the test made Ames a hero to environmentalists. However, he later changed his position on synthetic chemicals, following the realization that many naturally occurring substances are also carcinogenic. As a result, during the late 1980s and the 1990s, he came into conflict with environmentalists who had hailed him as an asset to their cause. Ames devoted much of his career to the study of cancer and aging, summarizing his research in more than 500 publications.
Education and career
Ames graduated from Cornell University in 1950, having earned a B.A. degree with a major in chemistry and a minor in biology. He then transferred to the biology department of the California Institute of Technology for his graduate studies. In 1953, after obtaining a Ph.D. in biochemistry, Ames moved to the National Institute of Arthritis and Metabolic Diseases (NIAMD; later the National Institute of Arthritis and Musculoskeletal and Skin Diseases) in Maryland, where he was a public health service fellow. While there he conducted research to isolate enzymes and genes involved in the biosynthesis of the amino acid histidine. He used the bacterium Salmonella as his organism of study. In 1962 Ames transitioned into the NIAMD laboratory of molecular biology, where he later began work on what would become the Ames test.
Ames remained at NIAMD until 1967, when he was appointed a professor of biochemistry and molecular biology at the University of California, Berkeley, where he was later made professor emeritus. Over his long career at Berkeley, Ames chaired the department of biochemistry and molecular biology and acted as director of the National Institute of Environmental Health Sciences Center. He also was a professor at the Berkeley graduate school and a senior research scientist at the Childrenās Hospital Oakland Research Institute in Oakland, California.
The Ames test
Ames owed much of his celebrity to the Ames test. The test targets chemical mutagens, the agents that tend to increase the frequency or extent of genetic mutation. The test was rapid and inexpensive, and thus it was more effective for initial mutagenicity screens than existing epidemiological surveys and animal tests. Since its development, the Ames test has been widely used to assess the mutagenic and carcinogenic risks of a large number of chemicals. The assessments have allowed scientists to determine whether various chemicals pose health risks to humans. Thanks to Amesās analysis, certain synthetic chemicals that once were commonly used have been banned. Tris, or tris(hydroxymethyl)aminomethane, a flame retardant used in childrenās sleepwear, was one of the most famous to be outlawed.
After developing the test, Ames collected data which showed that natural chemicals can be as carcinogenic as those manufactured in a laboratory. His findings prompted him to challenge the common wisdom that portrayed human-made chemicals as more dangerous than natural ones. Ames and colleagues claimed in a 2002 publication that a cup of coffee contained more than 1,000 chemicals. Only 30 of those chemicals had been investigated in animal cancer tests, 21 of which tested positive for mutagenicity. They concluded that there are more carcinogens in a cup of coffee than in a yearās exposure to pesticide residues. Chemicals of a carcinogenic nature had also been found in a number of other foods and beverages, including black table pepper, mushrooms, peanut butter, tea, and white bread.
Amesās findings led him to denounce what he saw as environmentalistsā idyllic and romantic view of a past world that never existed. He challenged their views, describing them as antitechnology. He also opposed California Proposition 128 in 1990, which would have resulted in changes to state laws concerning the regulation of pesticides, and he criticized the proposed ban on Alar (daminozide), a plant growth regulator that had been used primarily for apples. (Alar is listed as a carcinogen in California, but it and its metabolite, unsymmetrical dimethylhydrazine [UDMH], are considered probable carcinogens by the U.S. Environmental Protection Agency.)
Although Ames did not completely rule out external factors in the development of cancer, he maintained that cancer is a degenerative disease of old age. The fact that cancer rates were rising in the latter part of the 20th century, Ames argued, was the result not of an increase in pollution but of the fact that people were living longer. These controversial views caused heated debates within the scientific community and made Ames the subject of media interest. He saw himself as a popularizer who was trying to prevent cancer rather than find a cure for it. Amesās recipe for cancer prevention was as simple as it was provocative:
We should be eating more fruits and vegetables, so the main way to do that is to make them cheaper. Anything that makes fruits and vegetables more expensive may increase cancer.
Ames criticized the overreliance on results from high-dose animal tests for the classification of carcinogens. Together with his colleagues, he established a carcinogenesis rating system similar to the system for rating chemical toxicity. Known as the HERP (human exposure/rodent potency) index, the system rates carcinogenesis according to the degree to which a chemical induces tumour growth in experimental animals. Ames considered HERP to be āan index of possible hazard.ā Drawing on HERP data, he and colleagues wrote in a letter to the journal Science that a six-ounce container of apple juice had a UDMH HERP level of 0.0017 percent. This amount was a fraction of the HERP level reported for other foods.
Later research
From the 1980s Ames focused part of his research on aging. He demonstrated that mitochondrial decay is a major contributor to aging and age-related degenerative diseases. He carried out a series of experiments with the aim of reversing mitochondrial decay and argued for a balanced intake of micronutrients in the population to prevent disease and conditions such as obesity and malnutrition.
Legacy and awards
The underlying factor in Amesās research and the main source of his controversial character was his unabashed faith in the progress of science and technology. He was optimistic about scientific research and about scientistsā ability to understand cancer.
Ames received numerous awards for his environmental and scientific achievements. Among them were the 1985 Tyler Prize, the 1983 General Motors Cancer Research Foundation Prize, and the 1998 National Medal of Science. He was elected a member of the U.S. National Academy of Sciences in 1972 and was a member of the board of directors of the U.S. National Cancer Instituteās National Cancer Advisory Board from 1976 to 1982.